World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
21747
World Ranking
15760
National Ranking
7932

Paul J. Christos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul J. Christos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 572 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul J. Christos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul J. Christos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul J. Christos is affiliated with Cornell University in the United States and has contributed extensively to the field of Medicine with a particular focus on Genetics, Pulmonary and Respiratory Medicine, Oncology, Surgery, and Radiology, Nuclear Medicine, and Imaging.

Their research covers several specialized topics, including:

  • BRCA gene mutations in cancer
  • Prostate cancer treatment and research
  • Radiopharmaceutical chemistry and applications
  • COVID-19 and healthcare impacts
  • Genomics and rare diseases
  • Cancer immunotherapy and biomarkers
  • Meningioma and schwannoma management

Frequent publication venues where Paul J. Christos has contributed include:

  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • Blood
  • Journal of Neuro-Oncology
  • The Journal of Urology

Several key recent papers authored by or including Paul J. Christos are:

  • Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial (2021, The Lancet Oncology)
  • Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis (2021, Clinical Gastroenterology and Hepatology)
  • Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer (2020, American Journal of Obstetrics and Gynecology)
  • Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis (2022, Journal of Clinical Oncology)
  • Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling (2020, Journal of Clinical Oncology)

Frequent co-authors collaborating with Paul J. Christos include:

  • Charlene Thomas
  • Melissa K. Frey
  • Eloise Chapman-Davis
  • Kevin Holcomb
  • Ravi Sharaf

Best Publications

  • DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    Maria E. Figueroa;Sanne Lugthart;Yushan Li;Claudia Erpelinck-Verschueren

  • Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

    Abby B. Siegel;Emil I. Cohen;Allyson Ocean;Deborah Lehrer

  • Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

    Stefan Worgall;Dolan Sondhi;Neil R. Hackett;Barry Kosofsky

  • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

    Scott T. Tagawa;Matthew I. Milowsky;Michael Morris;Shankar Vallabhajosula

  • Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

    Peter Martin;Amy Chadburn;Paul Christos;Karen Weil

  • Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma

    Molly Yancovitz;Adam J. Litterman;Joanne Yoon;Elise Ng

  • Patterns of detection in patients with cutaneous melanoma.

    Mary S. Brady;Susan A. Oliveria;Paul J. Christos;Marianne Berwick

  • Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire (ETDQ-7).

    Edward D. McCoul;Vijay K. Anand;Vijay K. Anand;Paul J. Christos

  • Profile of 513 patients with alopecia areata : associations of disease subtypes with atopy, autoimmune disease and positive family history

    C Goh;M Finkel;PJ Christos;AA Sinha

  • Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies.

    Rache M. Simmons;Rache M. Simmons;Susan Kersey Fish;Lloyd Gayle;Lloyd Gayle;Gregory S. La Trenta;Gregory S. La Trenta

  • Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved?

    Rache M. Simmons;Meghan Brennan;Paul Christos;Valencia King

  • BiRD (Biaxin®[clarithromycin]/Revlimid®[lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma

    Ruben Niesvizky;David S. Jayabalan;Paul J. Christos;Jessica R. Furst

  • Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.

    Jia Ruan;Peter Martin;Bijal Shah;Stephen J. Schuster

  • Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

    Nasser K Altorki;Timothy E McGraw;Alain C Borczuk;Ashish Saxena

  • Increasing Incidence of Rectal Cancer in Patients Aged Younger Than 40 Years: An Analysis of the Surveillance, Epidemiology, and End Results Database

    Joshua E. Meyer;Tarun Narang;Felice H. Schnoll-Sussman;Mark B. Pochapin

  • FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

    Lale Kostakoglu;Stanley J. Goldsmith;John P. Leonard;Paul Christos

  • Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

    Rache Simmons;Sarmela Thevarajah;Meghan B. Brennan;Paul Christos

  • Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

    David E Rivadeneira;Rache M Simmons;Rache M Simmons;Paul J Christos;Paul J Christos;Kayane Hanna

  • MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.

    Praneil Patel;Hediyeh Baradaran;Diana Delgado;Gulce Askin

  • Construct validity for the LAPSIM laparoscopic surgical simulator

    A. J. Duffy;N. J. Hogle;H. McCarthy;J. I. Lew

Frequent Co-Authors

David M. Nanus
David M. Nanus Cornell University
Madhu Mazumdar
Madhu Mazumdar Icahn School of Medicine at Mount Sinai
Morton Coleman
Morton Coleman Cornell University
Neil H. Bander
Neil H. Bander Cornell University
John P. Leonard
John P. Leonard Cornell University
Himisha Beltran
Himisha Beltran Harvard University
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Douglas S. Scherr
Douglas S. Scherr Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine, it’s important to know there are many related fields and flexible educational pathways beyond the traditional MD. Online degrees can offer affordable and accessible options for advancing your healthcare career or shifting to a specialized role.

For those interested in healthcare management, online mha programs affordable provide a way to build leadership skills and pursue high-level positions within hospitals or clinics. Nursing professionals may want to explore dnp online programs cheap, which offer advanced clinical training to become leaders in nursing practice.

Pharmacy is another in-demand sector, and a 3 year online pharmd program can help you become a licensed pharmacist with a focus on flexibility and efficiency. Additionally, as technology reshapes healthcare, an online mhi degree opens doors to data management and health informatics roles.

These online degrees can provide a quicker, more accessible route to impactful healthcare careers, making them ideal for those seeking alternatives or enhancements to traditional medical study.

Best Scientists Citing Paul J. Christos

Trending Scientists